These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26815522)

  • 21. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
    Seregard S; Oskarsson M; Spångberg B
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uveal melanoma.
    Kashyap S; Meel R; Singh L; Singh M
    Semin Diagn Pathol; 2016 May; 33(3):141-7. PubMed ID: 26972224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological and morphological data of ocular melanocytic lesions.
    Baderca F; Solovan C; Boghian L
    Rom J Morphol Embryol; 2013; 54(1):77-83. PubMed ID: 23529312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological trends in uveal melanoma.
    Andreoli MT; Mieler WF; Leiderman YI
    Br J Ophthalmol; 2015 Nov; 99(11):1550-3. PubMed ID: 25904122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Melanoma of the uvea in young patients. Apropos of 3 cases].
    Ducasse A; Segal A; Favre F; Pluot M; Haye C
    Bull Soc Ophtalmol Fr; 1990 Feb; 90(2):195-7. PubMed ID: 2192809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The hierarchization of the prognostic factors in uveal malignant melanoma].
    Călugăru M; Mera M; Călugăru D
    Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic relevance of the P32 test in malignant melanoma of the uvea].
    Strempel I
    Dev Ophthalmol; 1982; 6():95-117. PubMed ID: 7095239
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant melanoma of the uvea in Iceland 1955-1979.
    Gíslason I; Magnússon B; Tulinius H
    Acta Ophthalmol (Copenh); 1985 Aug; 63(4):389-94. PubMed ID: 4050358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathological significance of expression of IGF-1R in uveal melanoma and its association with expression of p-AKT Thr308].
    Bao XL; Song H; Tang X
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):413-6. PubMed ID: 22932330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
    Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
    Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
    Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhegmatogenous retinal detachment after block excision of epithelial implantation cysts and tumors of the anterior uvea.
    Jonas JB; Groh MJ; Rummelt V; Naumann GO
    Ophthalmology; 1999 Oct; 106(10):1942-6. PubMed ID: 10519589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uveal melanoma: natural history and treatment options for metastatic disease.
    Wöll E; Bedikian A; Legha SS
    Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of prognostic factors in malignant melanoma of the uveal tract].
    Li B
    Zhonghua Yan Ke Za Zhi; 1990 Sep; 26(5):270-4. PubMed ID: 2086136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The morphological forms of malignant uveal melanoma].
    Simionescu C
    Oftalmologia; 1993; 37(1):3-11. PubMed ID: 8507607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.
    Shields CL; Kaliki S; Furuta M; Mashayekhi A; Shields JA
    Retina; 2012 Jul; 32(7):1363-72. PubMed ID: 22466491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
    Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.